Literature DB >> 8207718

The prevention and management of haemolytic disease of the newborn.

M Contreras1, M de Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8207718      PMCID： PMC1294514          DOI： 10.1177/014107689408700505

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  12 in total

1.  Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989.

Authors:  R M Hussey; C A Clarke
Journal:  BMJ       Date:  1991-08-24

2.  Have Liley charts outlived their usefulness?

Authors:  K H Nicolaides; C H Rodeck; R S Mibashan; J R Kemp
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661

Review 3.  Treatment options for the fetus with alloimmune hemolytic disease.

Authors:  J M Bowman
Journal:  Transfus Med Rev       Date:  1990-07

4.  Preventing rhesus babies: the Liverpool research and follow up.

Authors:  C A Clarke
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

5.  Consequences of fetomaternal haemorrhage after intrauterine transfusion.

Authors:  U Nicolini; N K Kochenour; P Greco; E A Letsky; R D Johnson; M Contreras; C H Rodeck
Journal:  BMJ       Date:  1988-11-26

6.  The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization.

Authors:  K H Nicolaides; J C Warenski; C H Rodeck
Journal:  Am J Obstet Gynecol       Date:  1985-06-01       Impact factor: 8.661

7.  Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay.

Authors:  S J Urbaniak; M A Greiss; R J Crawford; M J Fergusson
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

8.  High-dose intravenous IgG for the treatment of severe rhesus alloimmunization.

Authors:  M Margulies; L S Voto; E Mathet; M Margulies
Journal:  Vox Sang       Date:  1991       Impact factor: 2.144

9.  The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.

Authors:  L A Tovey; A Townley; B J Stevenson; J Taverner
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

10.  Clearance of Rh D-positive red cells with monoclonal anti-D.

Authors:  A Thomson; M Contreras; B Gorick; B Kumpel; G E Chapman; R S Lane; P Teesdale; N C Hughes-Jones; P L Mollison
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.